USPTO serial 86004143
BIOSITEHISTO OPTIBODIES
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 22, 2014
- Examiner
- DELGIZZI, RONALD ERNEST
- Law office
- TMEG LAW OFFICE 107
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with BIOSITEHISTO OPTIBODIES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael J. Hynak
Michael J. Hynak HYNAK & ASSOCIATES, PC812 S COURTHOUSE RDARLINGTON, VA 22204-2105UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry, science and photography; chemicals used in agriculture, horticulture and forestry, namely, chemical preparations for the treatment of seeds; adhesives for industrial use; amino acids for industrial purposes; biochemicals, namely, polypeptides for in vitro research use; biochemicals namely, precursors for in vitro genetic engineering use; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; stem cells for research or scientific purposes; reagents for scientific purposes; reagents for scientific or medical research use; reagents in kit form for conducting enzyme-linked immunosorbent assays, other than for medical or veterinary purposes; monoclonal antibodies for scientific use; chemical linking agents for scientific use in associating antibodies with radionuclides; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; chemical linkage compounds for scientific use in associating X-ray radiodiagnostic chemical compounds with antibodies; chemical components for producing a radio-labelled monoclonal antibody for industrial or scientific use; tagged antibodies for laboratory use; monoclonal antibodies for scientific use; reagents for scientific or medical research use; proteins for use in science; chemical preparations for use in dna analysis, other than for medical use; enzymes for scientific purposes; enzymes for technical use; enzymes, not for medical use, for detecting protein fractions; enzymes, not for medical use, for labelling protein fractions; enzymes, not for medical use, for labelling proteins; enzymes, not for medical use, for measuring protein fractions; enzymes, other than for medical use, for measuring proteins; enzymes, not for medical use, for use in detecting proteins; enzymes, not for medical or veterinary use; enzymes, not for medical use, for use in the continuous homogenous isothermal amplifications of specific dna templates; enzymes not for medical use, for use in the continuous homogenous isothermal amplifications of specific rna templates; immunological antibodies, other than for medical use; immunoglobulins, other than for medical use; Immunological antisera, other than for medical use; immunoassay reagents, other than for medical use; chemical reagents for use with immunoassay analyzers, other than for medical or veterinary use; chemicals for use in immuno-assay testing, other than medical or veterinary; tagged antibodies for laboratory use; amino acids for industrial purposes; antibodies, namely, mono or polyclonal antibodies for detection of neuronal or glial indications for scientific or research use | SECTION 8 - CANCELLED | — |
| 005 | Sanitary preparations for medical purposes; dietary supplements for humans and animals; plasters, materials for dressings; disinfectants; preparations for destroying vermin, namely, fungicides and herbicides; antibodies, namely, monoclonal antibodies for medical research and diagnostics to produce and or create proteins in blood, serum, plasma or tissue; human immune globulin, namely, immune globulin for medical research and diagnostics to produce and or create proteins in blood, serum, plasma or tissue; serums, namely, serums for medical research and diagnostics to produce and or create protein in blood, plasma or tissue; amino acids for veterinary purposes; chemical preparation for use in medical dna analysis in the nature of nucleic acids; enzymes for medical purposes; enzymes for veterinary purposes | SECTION 8 - CANCELLED | — |
| 042 | Scientific and technological services, namely, scientific research, research and design, analysis, testing in the field of medical research and diagnostics in connection with proteins in the blood, serum, plasma or tissue; industrial analysis and research services; design and development of computer hardware and software; laboratory services relating to the production of monoclonal antibodies; development of pharmaceutical preparations and medicines; laboratory services; research on the subject of pharmaceuticals; pharmaceutical research services; pharmaceutical research and development; pharmaceutical research and development services | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Nordic BioSite AB
- Other trademarks owned by Nordic BioSite AB
- Other trademarks owned by Nordic BioSite AB
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named BIOSITEHISTO OPTIBODIES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 13, 2021 | NCS8 | NOTICE OF CANCELLATION SEC. 8 EMAILED | — |
| Apr 12, 2021 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Oct 8, 2020 | PRA8 | POST REGISTRATION ACTION MAILED - SEC. 8 | — |
| Oct 8, 2020 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jul 9, 2020 | ES8R | TEAS SECTION 8 RECEIVED | — |
| Jul 22, 2019 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jul 22, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 6, 2014 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 6, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 16, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 29, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 27, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 21, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 21, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 19, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 5, 2014 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 5, 2014 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 5, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 13, 2014 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Feb 10, 2014 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jan 25, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 23, 2014 | ALIE | ASSIGNED TO LIE | — |
| Dec 30, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 30, 2013 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 30, 2013 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 30, 2013 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 30, 2013 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 12, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 12, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 12, 2013 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Oct 24, 2013 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 24, 2013 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 24, 2013 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 19, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 16, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 11, 2013 | NWAP | NEW APPLICATION ENTERED | — |